UK markets closed

Swedish Orphan Biovitrum AB (publ) (SOBI.ST)

Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
234.00+2.40 (+1.04%)
At close: 05:29PM CET
Currency in SEK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) 34.64
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 325.33%
S&P500 52-week change 3-7.75%
52-week high 3245.50
52-week low 3177.45
50-day moving average 3222.63
200-day moving average 3218.98

Share statistics

Avg vol (3-month) 3361.39k
Avg vol (10-day) 3270.42k
Shares outstanding 5295.99M
Implied shares outstanding 6N/A
Float 8187.79M
% held by insiders 14.01%
% held by institutions 170.59%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Sept 2022

Profitability

Profit margin 14.09%
Operating margin (ttm)23.50%

Management effectiveness

Return on assets (ttm)5.32%
Return on equity (ttm)10.65%

Income statement

Revenue (ttm)17.7B
Revenue per share (ttm)59.91
Quarterly revenue growth (yoy)6.30%
Gross profit (ttm)12.04B
EBITDA 6.2B
Net income avi to common (ttm)2.49B
Diluted EPS (ttm)10.13
Quarterly earnings growth (yoy)-4.70%

Balance sheet

Total cash (mrq)288M
Total cash per share (mrq)0.97
Total debt (mrq)10.18B
Total debt/equity (mrq)40.63
Current ratio (mrq)0.88
Book value per share (mrq)84.68

Cash flow statement

Operating cash flow (ttm)4.89B
Levered free cash flow (ttm)4B